SOX2 and hepatocellular carcinoma: Importantly, Wnt/β-catenin signaling inhibition by ICG-001, a specific Wnt/β-catenin signaling inhibitor, greatly decreased SOX2, c-MYC, and ABCG2 expression in ZNF687-transduced HCC cells (Supplementary Figure 6B).